Samalin Investment Counsel, LLC Tekla Life Sciences Investors Transaction History
Samalin Investment Counsel, LLC
- $274 Million
- Q3 2025
A detailed history of Samalin Investment Counsel, LLC transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Samalin Investment Counsel, LLC holds 18,546 shares of HQL stock, worth $295,808. This represents 0.1% of its overall portfolio holdings.
Number of Shares
18,546
Previous 21,782
14.86%
Holding current value
$295,808
Previous $279,000
2.87%
% of portfolio
0.1%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding HQL
# of Institutions
86Shares Held
9.86MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.02MShares$48.1 Million0.99% of portfolio
-
Penserra Capital Management LLC Orinda, CA794KShares$12.7 Million0.16% of portfolio
-
Morgan Stanley New York, NY766KShares$12.2 Million0.0% of portfolio
-
Royal Bank Of Canada Toronto, A6451KShares$7.2 Million0.0% of portfolio
-
Karpus Management, Inc. Pittsford, NY431KShares$6.87 Million0.23% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...